A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486

NCT03745625 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia
Sedation

Interventions

DRUG: HSK3486
DRUG: Propofol

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd